Valerian root draws interest, but evidence in dogs stays thin

Whole Dog Journal’s new focus on valerian root for dogs puts a familiar herbal ingredient back in front of pet parents and veterinary teams, especially as interest in nonprescription calming products keeps growing. The herb, Valeriana officinalis, is widely promoted for anxiety and sleep support, and it appears in both standalone supplements and multi-ingredient calming formulas for dogs. Still, the science behind it remains uneven, with much of the veterinary conversation built on traditional use, clinician experience, and extrapolation from human data rather than large canine trials. (nccih.nih.gov)

That gap between popularity and proof is the real backdrop here. NCCIH says evidence for valerian in people is limited and inconsistent, and that there’s not enough evidence to draw conclusions for anxiety, stress, or other conditions. In veterinary medicine, published evidence is even thinner. One of the more relevant dog studies in recent years looked not at valerian alone, but at a combination supplement containing tryptophan, valerian, and passiflora in dogs with firework fear. In that randomized, double-blinded, placebo-controlled study, dogs receiving the supplement plus behavioral and environmental guidance improved more than the placebo group, but the design doesn’t isolate valerian’s independent effect. (nccih.nih.gov)

That distinction matters when pet parents arrive asking whether valerian itself “works.” Veterinary commentary cited by PetMD describes valerian as a generally safe herb that may be used for noise phobias, separation anxiety, travel, veterinary visits, and sleep disruption, but those same experts acknowledge that dosing is imprecise and not established through clinical trials. They also stress that herbs shouldn’t replace a medical workup for insomnia or a structured treatment plan for clinically significant anxiety. In practice, valerian is often framed as an adjunct, not a primary therapy. (petmd.com)

Safety is where the conversation gets more concrete. ASPCA Animal Poison Control says valerian root generally has a wide margin of safety, though overingestion can lead to sedation, ataxia-like unsteadiness, and hypothermia. NCCIH, speaking to human use, says valerian is generally considered safe for short-term use but notes side effects such as headache, stomach upset, mental dullness, excitability, and vivid dreams, and warns that long-term safety is unknown. PetMD’s veterinary sources add a practical point for clinics: valerian may potentiate anesthetics, sedatives, anti-epileptic drugs, and possibly some other medications, which is why supplement history-taking matters before procedures and when evaluating neurologic or behavior cases. (aspca.org)

There’s also a regulatory and labeling angle that makes this more than a wellness trend story. FDA’s Center for Veterinary Medicine regulates animal drugs and animal food, but not every product marketed to pet parents as a calming aid is an FDA-approved animal drug. AAFCO notes that many products sold in ways similar to human dietary supplements don’t fit neatly into animal-feed rules, and that non-nutritional botanicals may be treated as drugs depending on intended use and claims. AAFCO also says FDA has objected to the term “dietary supplement” on animal products. For veterinary teams, that means product quality, claim language, and formulation consistency can vary, even when a label looks polished and consumer-friendly. (fda.gov)

Why it matters: Valerian sits at the intersection of nutrition, behavior, and client communication. Pet parents looking for gentler options may see it as low risk, but that can lead to underreporting unless clinicians ask directly about chews, tinctures, powders, and human supplements used at home. The bigger opportunity for veterinarians is to reframe the conversation: valerian may have a role for some dogs, especially in mild situational stress or as part of a broader plan, but evidence is limited, product oversight is inconsistent, and meaningful anxiety cases still require diagnosis, behavior modification, and, in some dogs, prescription treatment. That’s especially relevant in general practice, nutrition consults, anesthesia screening, and behavior referrals. (petmd.com)

What to watch: The next step to watch isn’t a single product launch so much as better evidence. More canine-specific trials, especially studies of valerian as a standalone ingredient with standardized dosing and defined endpoints, would help veterinarians counsel pet parents with more confidence. Until then, expect valerian to remain a commonly discussed supplement, but one best positioned as an adjunctive option that needs the same scrutiny clinicians would apply to any other biologically active compound. (pmc.ncbi.nlm.nih.gov)